Author:
Nasnas Patrice,Ravandi Farhad
Subject
Cancer Research,Oncology,Hematology
Reference33 articles.
1. Howlader N NA, Krapcho M, Miller D, et al. SEER cancer statistics review 2021 Available at: https://seer.cancer.gov/archive/csr/1975_2018/. Accessed: December 8, 2023.
2. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia;Lo-Coco;N Engl J Med,2013
3. Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial;Platzbecker;J Clin Oncol,2017
4. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial;Burnett;Lancet Oncol,2015
5. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial;Zhu;Lancet Oncol,2018